Pillstats
Rx only · Injection · Intramuscular

Promethazine Hydrochloride

Brands: Phenergan · Promethazine Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US21 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8745
US makers6 labelers
Packages21
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.541$1.08$1.62$2.16Sep 2025Mar 2026Jul 2026
$1.784
Latest avg · Jul 22, 2026
+3%
Since Sep 17, 2025
6
Active US suppliers
76%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7.8K16K23K31K2025 Q12025 Q22025 Q32025 Q42026 Q1
14K
Rx · 2026 Q1
52K
Units dispensed
-47%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hikma Pharmaceuticals USA Inc.unknown13SUPPLYING
Henry Schein Inc.unknown3SUPPLYING
Medical Purchasing Solutions, LLCunknown2SUPPLYING
ProPharma Distributionunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 21, 2023
    SHORTAGEDrug shortage: Promethazine Hydrochloride Injection (Hikma Pharmaceuticals USA, Inc.)

    Promethazine Hydrochloride Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy.